Daxor Corporation has introduced its ezBVA Lab diagnostic service for outpatient blood volume analysis at a healthcare facility in eastern Kansas. This service offers clinicians precise, 98% accurate blood volume measurements within 24 hours without the need for capital equipment or lab infrastructure. By providing objective data on blood, plasma, and red cell volume, the service helps optimize patient treatment, reduce hospital readmissions, and lower healthcare costs. This expansion strengthens Daxor's presence in the Midwest and supports value-based care improvements.
Halper Sadeh LLC is investigating whether the sales and mergers involving Utz Brands, BioLife Solutions, and Northrim BanCorp provide fair financial terms to their shareholders. The firm suspects insiders might gain benefits not available to ordinary...
Mesoblast announced $36 million in net revenue for Q4 and $115 million for the first full year following FDA approval of its Ryoncil therapy, used to treat steroid-refractory acute graft versus host disease (SR-aGvHD) in children. The company is expa...
Fortuna Mining Corp. has approved a $109 million expansion of its Séguéla Gold Mine in Côte d’Ivoire, increasing processing capacity by 30% from 1.75 to 2.3 million tonnes per annum and improving gold recovery to 94.5%. This expansion includes upgrad...
Gumi Inc. and SBI have launched SBI Crypto Fund I, a $18.3 million investment vehicle focused on Bitcoin and major altcoins, starting August 1, 2026. The fund uses strategies like staking, hedging, and portfolio rebalancing and is backed by major inv...
Bittensor (TAO) has declined 2.1% in the last 24 hours and nearly 4% over the past week, breaking below a key support zone around $194. Despite a mid-June bounce from $194 to $291, the recovery lacked strength, with weekly indicators showing sustaine...
